You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 154 No. 13, 11 July 1994 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigations
 •Online Features
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1306)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation

Analysis of Pooled Data From Five Randomized Controlled Trials

Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study

Arch Intern Med. 1994;154(13):1449-1457.


Abstract



Background and Methods
Atrial fibrillation is associated with an increased risk of ischemic stroke. Data on individual patients were pooled from five recently completed randomized trials comparing warfarin (all studies) or aspirin (the Atrial Fibrillation, Aspirin, Anticoagulation Study and the Stroke Prevention in Atrial Fibrillation Study) with control in patients with atrial fibrillation. The purpose of the analysis was to (1) identify patient features predictive of a high or low risk of stroke, (2) assess the efficacy of antithrombotic therapy in major patient subgroups (eg, women), and (3) obtain the most precise estimate of the efficacy and risks of antithrombotic therapy in atrial fibrillation. For the warfarin-control comparison there were 1889 patient-years receiving warfarin and 1802 in the control group. For the aspirin-placebo comparison there were 1132 patient-years receiving aspirin and 1133 receiving placebo. The daily dose of aspirin was 75 mg in the Atrial Fibrillation, Aspirin, Anticoagulation Study and 325 mg in the Stroke Prevention in Atrial Fibrillation Study. To monitor warfarin dosage, three studies used prothrombin time ratios and two used international normalized ratios. The lowest target intensity was a prothrombin time ratio of 1.2 to 1.5 and the highest target intensity was an international normalized ratio of 2.8 to 4.2. The primary end points were ischemic stroke and major hemorrhage, as assessed by each study.

Results
At the time of randomization the mean age was 69 years and the mean blood pressure was 142/82 mm Hg. Forty-six percent of the patients had a history of hypertension, 6% had a previous transient ischemic attack or stroke, and 14% had diabetes. Risk factors that predicted stroke on multivariate analyses in control patients were increasing age, history of hypertension, previous transient ischemic attack or stroke, and diabetes. Patients younger than 65 years who had none of the other predictive factors (15% of all patients) had an annual rate of stroke of 1.0%, 95% confidence interval (CI) 0.3% to 3.0%. The annual rate of stroke was 4.5% for the control group and 1.4% for the warfarin group (risk reduction, 68%; 95% CI, 50% to 79%). The efficacy of warfarin was consistent across all studies and subgroups of patients. In women, warfarin decreased the risk of stroke by 84% (95% CI, 55% to 95%) compared with 60% (95% CI, 35% to 76%) in men. The efficacy of aspirin was not as consistent. The risk reduction with 75 mg of aspirin in the Atrial Fibrillation, Aspirin, Anticoagulation Study was 18% (95% CI, 60% to 58%), and with 325 mg of aspirin in the Stroke Prevention in Atrial Fibrillation Study the risk reduction was 44% (95% CI, 7% to 66%). When both studies were combined the risk reduction was 36% (95% CI, 4% to 57%). The annual rate of major hemorrhage (intracranial bleeding or a bleed requiring hospitalization or 2 units of blood) was 1.0% for the control group, 1.0% for the aspirin group, and 1.3% for the warfarin group.

Conclusion
In these five randomized trials warfarin consistently decreased the risk of stroke in patients with atrial fibrillation (a 68% reduction in risk) with virtually no increase in the frequency of major bleeding. Patients with atrial fibrillation younger than 65 years without a history of hypertension, previous stroke or transient ischemic attack, or diabetes were at very low risk of stroke even when not treated. The efficacy of aspirin was less consistent. Further studies are needed to clarify the role of aspirin in atrial fibrillation.

(Arch Intern Med. 1994;154:1449-1457)




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

The Underuse of Warfarin Treatment in the Elderly
Valery A. Portnoi, Lawrence M. Brass, Harlan M. Krumholz, Jeanne D. Scinto, Deepak Mathur, and Martha Radford
Arch Intern Med. 1999;159(12):1374-1375.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improved screening for silent atrial fibrillation after ischaemic stroke
Doliwa Sobocinski et al.
Europace 2012;0:eur431v1-eur431.
ABSTRACT | FULL TEXT  

Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Ageno et al.
Chest 2012;141:e44S-e88S.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
You et al.
Chest 2012;141:e531S-e575S.
ABSTRACT | FULL TEXT  

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
Banerjee et al.
Eur J Heart Fail 2012;0:hfs005v1-hfs005.
ABSTRACT | FULL TEXT  

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
Pisters et al.
Europace 2012;0:eur406v1-eur406.
ABSTRACT | FULL TEXT  

Coumarins and survival in incident dialysis patients
Knoll et al.
Nephrol Dial Transplant 2012;27:332-337.
ABSTRACT | FULL TEXT  

Risk factors of vitamin K antagonist overcoagulation
Marie et al.
QJM 2012;105:53-62.
ABSTRACT | FULL TEXT  

Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
Olesen et al.
Chest 2012;141:147-153.
ABSTRACT | FULL TEXT  

Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation
Raunso et al.
Eur Heart J 2011;0:ehr454v1-ehr454.
ABSTRACT | FULL TEXT  

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association
Smith et al.
J Am Coll Cardiol 2011;58:2432-2446.
FULL TEXT  

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation
Smith et al.
Circulation 2011;124:2458-2473.
FULL TEXT  

Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation.
Toumanides et al.
J Am Coll Cardiol 2011;58:2236-2240.
ABSTRACT | FULL TEXT  

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Oldgren et al.
ANN INTERN MED 2011;155:660-667.
ABSTRACT | FULL TEXT  

Pacemaker clinic: an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment
Cabrera et al.
Europace 2011;13:1574-1579.
ABSTRACT | FULL TEXT  

Bleeding and Stroke Risk in a Real-world Prospective Primary Prevention Cohort of Patients With Atrial Fibrillation
Poli et al.
Chest 2011;140:918-924.
ABSTRACT | FULL TEXT  

The role of echocardiography in percutaneous left atrial appendage occlusion
Chue et al.
Eur Heart J Cardiovasc Imaging 2011;12:i3-i10.
ABSTRACT | FULL TEXT  

The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery: Executive Summary
Fernando et al.
Ann. Thorac. Surg. 2011;92:1144-1152.
FULL TEXT  

Dual-Enhanced Cardiac CT for Detection of Left Atrial Appendage Thrombus in Patients With Stroke: A Prospective Comparison Study With Transesophageal Echocardiography
Hur et al.
Stroke 2011;42:2471-2477.
ABSTRACT | FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery
Writing Committee Members et al.
Stroke 2011;42:e464-e540.
FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery
Writing Committee Members et al.
Stroke 2011;42:e420-e463.
FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery
Writing Committee Members et al.
Circulation 2011;124:e54-e130.
FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery
Brott et al.
Circulation 2011;124:489-532.
FULL TEXT  

Atrial Fibrillation: Outpatient Presentation and Management
Ezekowitz et al.
Circulation 2011;124:95-99.
FULL TEXT  

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
Shah and Gage
Circulation 2011;123:2562-2570.
ABSTRACT | FULL TEXT  

An Evaluation of the CHADS2 Stroke Risk Score in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Revascularization
Ruiz-Nodar et al.
Chest 2011;139:1402-1409.
ABSTRACT | FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine and Society for Vascular Surgery Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography
Writing Committee Members: et al.
Journal of NeuroInterventional Surgery 2011;3:100-130.
FULL TEXT  

Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance
Jain and Gallagher
Heart 2011;97:762-765.
FULL TEXT  

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
Lip et al.
Europace 2011;13:723-746.
ABSTRACT | FULL TEXT  

What are the costs of atrial fibrillation?
Blomstrom Lundqvist et al.
Europace 2011;13:ii9-ii12.
ABSTRACT | FULL TEXT  

Usability of an Atrial Fibrillation Anticoagulation Decision-Support Tool
Wess et al.
Journal of Primary Care & Community Health 2011;2:100-106.
ABSTRACT  

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2011;57:e101-e198.
FULL TEXT  

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Fuster et al.
Circulation 2011;123:e269-e367.
FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography
Brott et al.
J Am Coll Cardiol 2011;57:1002-1044.
FULL TEXT  

Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial Fibrillation
Daccarett et al.
J Am Coll Cardiol 2011;57:831-838.
ABSTRACT | FULL TEXT  

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
Brott et al.
Vasc Med 2011;16:35-77.
 

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Olesen et al.
BMJ 2011;342:d124-d124.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Freeman et al.
ANN INTERN MED 2011;154:1-11.
ABSTRACT | FULL TEXT  

Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Eckman et al.
Circ Cardiovasc Qual Outcomes 2011;4:14-21.
ABSTRACT | FULL TEXT  

A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation
Fu et al.
Europace 2011;13:31-36.
ABSTRACT | FULL TEXT  

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Furie et al.
Stroke 2011;42:227-276.
ABSTRACT | FULL TEXT  

Surgical Treatment of Atrial Fibrillation: The Time Is Now
Poynter et al.
Ann. Thorac. Surg. 2010;90:2079-2086.
ABSTRACT | FULL TEXT  

Recent advances in oral anticoagulation for atrial fibrillation
Singh et al.
Ther Adv Cardiovasc Dis 2010;4:395-407.
ABSTRACT  

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
Yang et al.
Europace 2010;12:1666-1672.
ABSTRACT | FULL TEXT  

Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort
Lip et al.
Stroke 2010;41:2731-2738.
ABSTRACT | FULL TEXT  

What's new in treating older adults?
MESSINGER-RAPPORT
Cleveland Clinic Journal of Medicine 2010;77:770-790.
ABSTRACT | FULL TEXT  

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey
Pisters et al.
Chest 2010;138:1093-1100.
ABSTRACT | FULL TEXT  

Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation
Medi et al.
Stroke 2010;41:2705-2713.
ABSTRACT | FULL TEXT  

Prevalence and Predictors of Paroxysmal Atrial Fibrillation on Holter Monitor in Patients With Stroke or Transient Ischemic Attack
Alhadramy et al.
Stroke 2010;41:2596-2600.
ABSTRACT | FULL TEXT  

The Evolving Field of Stroke Prevention in Patients With Atrial Fibrillation
Ezekowitz et al.
Stroke 2010;41:S17-S20.
ABSTRACT | FULL TEXT  

Long-term Use of Anti-inflammatory Drugs and Risk of Atrial Fibrillation
De Caterina et al.
Arch Intern Med 2010;170:1450-1455.
ABSTRACT | FULL TEXT  

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications for Thromboprophylaxis
Marinigh et al.
J Am Coll Cardiol 2010;56:827-837.
ABSTRACT | FULL TEXT  

Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W
De Caterina et al.
Eur Heart J 2010;31:2133-2140.
ABSTRACT | FULL TEXT  

Vernakalant: A novel agent for the termination of atrial fibrillation
Finnin
Am J Health Syst Pharm 2010;67:1157-1164.
ABSTRACT | FULL TEXT  

The environmental epidemiology of atrial arrhythmogenesis
Whitsel and Avery
J. Epidemiol. Community Health 2010;64:587-590.
ABSTRACT | FULL TEXT  

Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?
McCready et al.
Europace 2010;12:927-932.
ABSTRACT | FULL TEXT  

The evaluation of pulmonary vein isolation and wide-area left atrial ablation to treat atrial fibrillation in patients with implanted permanent pacemakers: the Previously Paced Pulmonary Vein Isolation Study
Veasey et al.
Heart 2010;96:1037-1042.
ABSTRACT | FULL TEXT  

Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy: The Bleeding With Antithrombotic Therapy (BAT) Study
Toyoda et al.
Stroke 2010;41:1440-1444.
ABSTRACT | FULL TEXT  

The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines
Pisters et al.
Europace 2010;12:779-784.
ABSTRACT | FULL TEXT  

Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
Nault et al.
Eur Heart J 2010;31:1046-1054.
ABSTRACT | FULL TEXT  

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
Friberg et al.
Eur Heart J 2010;31:967-975.
ABSTRACT | FULL TEXT  

Stroke risk in AF: do AF patterns matter?
Lubitz et al.
Eur Heart J 2010;31:908-910.
FULL TEXT  

Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon
Ntep-Gweth et al.
Europace 2010;12:482-487.
ABSTRACT | FULL TEXT  

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation
Lip et al.
Chest 2010;137:263-272.
ABSTRACT | FULL TEXT  

Chagas Disease: Independent Risk Factor for Stroke
Paixao et al.
Stroke 2009;40:3691-3694.
ABSTRACT | FULL TEXT  

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
Haywood et al.
J Am Coll Cardiol 2009;54:2023-2031.
ABSTRACT | FULL TEXT  

Perioperative management of warfarin and antiplatelet therapy
JAFFER
Cleveland Clinic Journal of Medicine 2009;76:S37-S44.
ABSTRACT | FULL TEXT  

Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment
Orken et al.
Stroke 2009;40:3638-3640.
ABSTRACT | FULL TEXT  

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study
Glotzer et al.
Circ Arrhythm Electrophysiol 2009;2:474-480.
ABSTRACT | FULL TEXT  

Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
Piccini et al.
J Am Coll Cardiol 2009;54:1280-1289.
ABSTRACT | FULL TEXT  

Reducing Stroke Rates in Patients With Atrial Fibrillation: How Low Can We Go?
Ezekowitz et al.
Circulation 2009;120:1169-1170.
FULL TEXT  

The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Singer et al.
ANN INTERN MED 2009;151:297-305.
ABSTRACT | FULL TEXT  

Concurrent prophylactic left atrial appendage exclusion: results from a randomized controlled trial pilot study
Nagpal et al.
Eur J Cardiothorac Surg 2009;36:553-557.
ABSTRACT | FULL TEXT  

Optimal Level of Oral Anticoagulant Therapy for the Prevention of Arterial Thrombosis in Patients With Mechanical Heart Valve Prostheses, Atrial Fibrillation, or Myocardial Infarction: A Prospective Study of 4202 Patients
Torn et al.
Arch Intern Med 2009;169:1203-1209.
ABSTRACT | FULL TEXT  

Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study
Singer et al.
Circ Cardiovasc Qual Outcomes 2009;2:297-304.
ABSTRACT | FULL TEXT  

Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation
Hart and Pearce
Stroke 2009;40:2607-2610.
FULL TEXT  

Left Atrial Appendage Thrombi in Stroke Patients: Detection with Two-Phase Cardiac CT Angiography versus Transesophageal Echocardiography1
Hur et al.
Radiology 2009;251:683-690.
ABSTRACT | FULL TEXT  

Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Feng et al.
Circulation 2009;119:2490-2497.
ABSTRACT | FULL TEXT  

Cost of Hospital Admission for Antiarrhythmic Drug Initiation in Atrial Fibrillation
Kim et al.
The Annals of Pharmacotherapy 2009;43:840-848.
ABSTRACT | FULL TEXT  

Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score
Kleemann et al.
Eur Heart J Cardiovasc Imaging 2009;10:383-388.
ABSTRACT | FULL TEXT  

Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography
Uretsky et al.
Eur Heart J Cardiovasc Imaging 2009;10:363-371.
ABSTRACT | FULL TEXT  

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators
van Walraven et al.
Stroke 2009;40:1410-1416.
ABSTRACT | FULL TEXT  

Sex Differences in Stroke Epidemiology: A Systematic Review
Appelros et al.
Stroke 2009;40:1082-1090.
ABSTRACT | FULL TEXT  

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial
Massie et al.
Circulation 2009;119:1616-1624.
ABSTRACT | FULL TEXT  

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Go et al.
Circulation 2009;119:1363-1369.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.